Hlscience Co. Ltd. (239610) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hlscience Co. Ltd. (239610:KRX), powered by AI.

Current Price
₩5,780
P/E Ratio
-2.6
Market Cap
31.2B
Sector
Healthcare
What is the Hlscience Co. Ltd. stock price forecast?

Hlscience Co. Ltd. is currently trading at ₩5,780. View real-time AI analysis on Alpha Lenz.

What is Hlscience Co. Ltd. insider trading activity?

View the latest insider trading data for Hlscience Co. Ltd. on Alpha Lenz.

What is Hlscience Co. Ltd.'s P/E ratio?

Hlscience Co. Ltd.'s P/E ratio is -2.6.

Hlscience Co. Ltd.

KRX · 239610
₩5,780+170(+3.03%)Market closedKRX regular session 09:00–15:30 KST
Ask about Hlscience Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Hlscience Co. Ltd. trades at a P/E of -2.6 (undervalued) with modest ROE of -13.5%.

Ask for details

Company Overview

Hlscience Co. Ltd. is a leading innovator in the nutraceutical and biotechnology industries, specializing in the research and development of functional health products. The company focuses on creating high-quality, scientifically-backed supplements and dietary products aimed at improving consumer health and wellness. Hlscience Co. Ltd. invests significantly in clinical research to validate the efficacy of its products, ensuring that their offerings meet stringent health standards and consumer expectations. Operating in a market driven by increasing health awareness and demand for preventive health measures, Hlscience Co. Ltd. serves a wide range of customers including health-conscious consumers, healthcare professionals, and wellness-oriented businesses. Their product range often includes sophisticated formulations targeting specific health conditions such as immune support, cognitive enhancement, and metabolic health. Hlscience Co. Ltd. holds a pivotal role in the growing global nutraceutical market, where the focus lies on innovation and efficacy. By leveraging advanced biotechnological processes, the company not only meets current health trends but also anticipates future needs, cementing its status as a leader in the health sciences sector.

CEO이해연
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees71

Company Statistics

FY 2025

Profile

₩31,166,424,700Market Cap
₩16,705,710,060Revenue
5.39MShares Out
71Employees

Margins

51.26%Gross
-37.18%EBITDA
-66.15%Operating
-70.94%Pre-Tax
-71.53%Net

Valuation

-2.62P/E
0.38P/B
1.87EV/Sales
-4.76EV/EBITDA
-4.12P/FCF

Growth (CAGR)

-31.84%Rev 3Yr
-34.91%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-13.07%ROA
-13.45%ROE
-12.09%ROIC

Financial Health

₩1,777,039,970Cash & Cash Equivalents
₩497,482,450Net Debt
2.75%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Hlscience Co. Ltd. (ticker: 239610) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 71 employees. Market cap is $31.2B.

The current price is ₩5,780 with a P/E ratio of -2.62x and P/B of 0.38x.

ROE is -13.45% and operating margin is -66.15%. Annual revenue is $16.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Hlscience Co. Ltd. (239610) Stock Forecast 2026 ₩5,780 — Price, Financials & Analyst Targets | Alpha Lenz